PROFILE

2005.03 ~ 2008.02     Sogang Univ. MS
1999.03 ~ 2005.02     Sogang Univ. BS

1.Bio Investment Manager (2021 – Present)
Leading investments in the bio-healthcare sector as Head of Bio Investment

2.R&D Asset Spin-off and JV Formation (2018 – 2020)
Planned and executed a new corporate spin-off using R&D pipelines (diabetes, obesity, NAFLD)

Led technology transfer and JV pharmaceutical plant projects in Saudi Arabia and Indonesia

3.International Partnership & Localization (2018 – 2020)
Managed overseas manufacturing/supply partnerships

Executed local JV establishment, equity investment, product localization, and tech transfer

4.Regulatory Consulting & Global Affairs (2014 – 2019)
Advised MFDS on export-related regulatory strategy (Brazil, India)

Led global regulatory affairs for biosimilars and new drugs (e.g., Darbepoetin alfa, Ustekinumab, Evogliptin)

Participated in key FDA and EMA meetings

5.Biopharmaceutical Development (2007 – 2013)
Developed purification processes and analytical methods for biosimilars and recombinant proteins

Transferred manufacturing processes for biologics and monoclonal antibodies (e.g., Bevacizumab)